[1]
Hermawana, A.; Putri, H. Current report of natural product development against breast cancer stem cells. Int. J. Biochem. Cell Biol., 2018, 104, 114-132.
[2]
Guo, Z. The modification of natural products for medical use. Acta Pharm. Sin. B, 2017, 7, 119-136.
[3]
Ferrari, E.; Pignedoli, F.; Imbriano, C.; Marverti, G.; Basile, V.; Venturi, E.; Saladini, M. Newly synthesized curcumin derivatives: Crosstalk between chemico-physical properties and biological activity. J. Med. Chem., 2011, 54, 8066-8077.
[4]
Zhang, L.; Zong, H.; Lu, H.; Gong, J.; Fenfen, M. Discovery of novel anti-tumor curcumin analogues from the optimization of curcumin scaffold. Med. Chem. Res., 2017, 26, 2468-2476.
[5]
Nelson, K.M.; Dahlin, J.L.; Bisson, J.; Graham, J.; Pauli, G.F.; Walters, M.A. The essential medicinal chemistry of curcumin. J. Med. Chem., 2017, 60, 1620-1637.
[6]
Okuda, M.; Hijikuro, I.; Fujita, Y.; Teruya, T.; Kawakami, H.; Takahashi, T.; Sugimoto, H. Design and synthesis of curcumin derivatives as Tau and amyloid β dual aggregation inhibitors. Bioorg. Med. Chem. Lett., 2016, 26, 5024-5028.
[7]
Wang, Z.; Zou, P.; Li, C.; He, W.; Xiao, B.; Fang, Q.; Chen, W.; Zheng, S.; Zhao, Y.; Cai, Y.; Liang, G. Synthesis and biological evaluation of novel semiconservative monocarbonyl analogs of curcumin as anti-inflammatory agents. MedChemComm, 2015, 6, 1328-1339.
[8]
Thakur, A.; Manohar, S.; Vélez Gerena, C.E.; Zayas, B.; Kumar, V.; Malhotra, S.V.; Rawat, D.S. Novel 3,5-bis(arylidiene)-4-piperidone based monocarbonyl analogs of curcumin: anticancer activity evaluation and mode of action study. MedChemComm, 2014, 5, 576-586.
[9]
Schmitt, F.; Gold, M.; Begemann, G.; Andronache, I.; Biersack, B.; Schobert, R. Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects. Bioorg. Med. Chem., 2017, 25, 4894-4903.
[10]
Addala, E.; Rafiei, H.; Das, S.; Bandy, B.; Das, U.; Karki, S.S.; Dimmock, J.R. 3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathione oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells. Bioorg. Med. Chem. Lett., 2017, 27, 3669-3673.
[12]
Potter, E.; Jha, M.; Bhullar, K.S.; Rupasinghe, H.P.V.; Balzarini, J.; Jha, A. Investigation of fatty acid conjugates of 3,5-bisarylmethylene-4-piperidone derivatives as antitumor agents and human topoisomerase-IIα inhibitors. Bioorg. Med. Chem., 2015, 23, 411-421.
[23]
Choudhary, S.; Singh, P.K.; Verma, H.; Singh, H.; Silakari, O. Success stories of natural product-based hybrid molecules for multifactorial diseases. Eur. J. Med. Chem., 2018, 151, 62-97.
[24]
Dimmock, J.R.; Padmanilayam, M.P.; Puthucode, R.N.; Nazarali, A.J.; Motaganahalli, N.L.; Zello, G.A.; Quail, J.W.; Oloo, E.O.; Kraatz, H-B.; Prisciak, J.S.; Allen, T.M.; Santos, C.L.; Balzarini, J.; De Clercq, E.; Manavathu, E.K. A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues. J. Med. Chem., 2001, 44, 586-593.
[25]
Katsori, A-M.; Chatzopoulou, M.; Dimas, K.; Kontogiorgis, C.; Patsilinakos, A.; Trangas, T.; Hadjipavlou-Litina, D. Curcumin analogues as possible anti-proliferative & anti-inflammatory agents. Eur. J. Med. Chem., 2011, 46, 2722-2735.
[26]
Ismail, N.S.M.; George, R.F.; Serya, R.A.T.; Baselious, F.N.; El-Manawaty, M.; Shalaby, E.M.; Girgis, A.S. Rational design, synthesis and 2D-QSAR studies of antiproliferative tropane-based compounds. RSC Advances, 2016, 6, 101911-101923.
[27]
George, R.F.; Panda, S.S.; Shalaby, E.M.; Srour, A.M. Ahmed, Farag, I.S.; Girgis, A.S. Synthesis and molecular modeling studies of indole-based antitumor agents. RSC Advances, 2016, 6, 45434-45451.
[28]
Girgis, A.S.; Panda, S.S.; Aziz, M.N.; Steel, P.J.; Hall, C.D.; Katritzky, A.R. Rational design, synthesis, and 2D-QSAR study of anti-oncological alkaloids against hepatoma and cervical carcinoma. RSC Advances, 2015, 5, 28554-28569.
[31]
Srour, A.M.; Panda, S.S.; Salman, A.M.M.; El-Manawaty, M.A.; George, R.F.; Shalaby, E.M.; Fitch, A.N.; Fawzy, N.G.; Girgis, A.S. Synthesis & molecular modeling studies of bronchodilatory active indole-pyridine conjugates. Future Med. Chem., 2018, 10, 1787-1804.
[32]
Soliman, E.A.; Panda, S.S.; Aziz, M.N.; Shalaby, E.M.; Mishriky, N.; Asaad, F.M.; Girgis, A.S. Synthesis, molecular modeling studies and bronchodilation properties of nicotinonitrile containing-compounds. Eur. J. Med. Chem., 2017, 138, 920-931.
[33]
Faidallah, H.M.; Girgis, A.S.; Tiwari, A.D.; Honkanadavar, H.H.; Thomas, S.J.; Samir, A.; Kalmouch, A.; Alamry, K.A.; Khan, K.A.; Ibrahim, T.S.; Al-Mahmoudy, A.M.M.; Asiri, A.M.; Panda, S.S. Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates. Eur. J. Med. Chem., 2018, 143, 1524-1534.
[34]
Yamashita, M.; Tahara, T.; Hayakawa, S.; Matsumoto, H.; Wada, S-I.; Tomioka, K.; Iida, A. Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors. Bioorg. Med. Chem., 2018, 26, 1920-1928.
[35]
Matsumoto, H.; Yamashita, M.; Tahara, T.; Hayakawa, S.; Wada, S-I.; Tomioka, K.; Iida, A. Design, synthesis, and evaluation of DNA topoisomerase II-targeted nucleosides. Bioorg. Med. Chem., 2017, 25, 4133-4144.
[36]
Li, D.; Yuan, Z.; Chen, S.; Zhang, C.; Song, L.; Gao, C.; Chen, Y.; Tan, C.; Jiang, Y. Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors. Bioorg. Med. Chem., 2017, 25, 3437-3446.
[37]
Jha, A.; Duffield, K.M.; Ness, M.R.; Ravoori, S.; Andrews, G.; Bhullar, K.S.; Vasantha Rupasinghe, H.P.; Balzarini, J. Curcumin-inspired cytotoxic 3,5-bis(arylmethylene)-1-(N-(orthosubstituted aryl)maleamoyl)-4-piperidones: A novel group of topoisomerase II alpha inhibitors. Bioorg. Med. Chem., 2015, 23, 6404-6417.
Download PDF Flyer